PCT Rule 13bis — Inventions Relating to Biological Material (MPEP Coverage Index) – BlueIron IP

PCT Rule 13bis Inventions Relating to Biological Material

Source: Patent Cooperation Treaty (PCT)BlueIron Update:

This page consolidates MPEP guidance interpreting PCT Rule 13bis, including 6 rules from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only, it is not legal advice.

Summary

This section addresses the handling of deposits for inventions involving biological material in PCT filings, allowing designated offices to disregard deposits made with non-notified institutions.

What this section covers

  • Defines that this section addresses the handling of deposits for inventions involving biological material in PCT filings.

Key obligations

  • States that designated offices may disregard deposits made with institutions not notified by them under Rule 13bis.7(b).
  • Notes that this section does not require the deposit to be made with a notified institution, but allows designated offices to disregard such deposits.

Practice notes

  • Advise practitioners to ensure deposits are made with notified institutions to avoid disregarding the deposit by designated offices.
  • Warn against making deposits with non-notified institutions to prevent potential rejection or disregard by designated offices.

Based on MPEP Last Modified: 10/30/2024 08:50:22